These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14513913)

  • 1. Does the brain noradrenaline network mediate the effects of the CO2 challenge?
    Bailey JE; Argyropoulos SV; Lightman SL; Nutt DJ
    J Psychopharmacol; 2003 Sep; 17(3):252-9. PubMed ID: 14513913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the brain noradrenaline network mediate the effects of the CO2 challenge?
    Bellodi L; Caldirola D; Bertani A
    J Psychopharmacol; 2003 Sep; 17(3):263-4; discussion 267-8. PubMed ID: 14513915
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of CO2 challenges.
    Griez E; Schruers K
    J Psychopharmacol; 2003 Sep; 17(3):260-2; discussion 267-8. PubMed ID: 14513914
    [No Abstract]   [Full Text] [Related]  

  • 4. Does the brain noradrenaline network mediate the effects of the CO2 challenge?
    Gorman JM
    J Psychopharmacol; 2003 Sep; 17(3):265-6; discussion 267-8. PubMed ID: 14513916
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
    Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavioral sensitivity to carbon dioxide (CO
    Winter A; Ahlbrand R; Naik D; Sah R
    Neuroscience; 2017 Mar; 346():423-433. PubMed ID: 28087339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS; Coplan JD; Pine DS; Martinez JA; Klein DF; Gorman JM
    Psychiatry Res; 1999 May; 86(2):93-8. PubMed ID: 10397411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus coeruleus noradrenaline depletion and its differential impact on CO
    Ripamonte GC; Fonseca EM; Frias AT; Patrone LGA; Vilela-Costa HH; Silva KSC; Szawka RE; Bícego KC; Zangrossi H; Plummer NW; Jensen P; Gargaglioni LH
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111063. PubMed ID: 38908504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.
    Bailey JE; Argyropoulos SV; Kendrick AH; Nutt DJ
    Depress Anxiety; 2005; 21(1):18-25. PubMed ID: 15782425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The four-dimensional stress test: psychological, sympathetic-adrenal-medullary, parasympathetic and hypothalamic-pituitary-adrenal responses following inhalation of 35% CO2.
    Wetherell MA; Crown AL; Lightman SL; Miles JN; Kaye J; Vedhara K
    Psychoneuroendocrinology; 2006 Jul; 31(6):736-47. PubMed ID: 16621326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 7.5% CO2 challenge in generalized anxiety disorder.
    Seddon K; Morris K; Bailey J; Potokar J; Rich A; Wilson S; Bettica P; Nutt DJ
    J Psychopharmacol; 2011 Jan; 25(1):43-51. PubMed ID: 20233897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon dioxide induced panic attack in panic disorder in Japan.
    Sasaki I; Akiyoshi J; Sakurai R; Tsutsumi T; Ono H; Yamada K; Fujii I
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1145-57. PubMed ID: 8938816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers.
    Argyropoulos SV; Bailey JE; Hood SD; Kendrick AH; Rich AS; Laszlo G; Nash JR; Lightman SL; Nutt DJ
    Psychoneuroendocrinology; 2002 Aug; 27(6):715-29. PubMed ID: 12084664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA; Schruers KR; Maes M; Griez EJ
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.
    Sullivan GM; Coplan JD; Kent JM; Gorman JM
    Biol Psychiatry; 1999 Nov; 46(9):1205-18. PubMed ID: 10560026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking.
    Garcia-Leal C; Parente AC; Del-Ben CM; Guimarães FS; Moreira AC; Elias LL; Graeff FG
    Psychiatry Res; 2005 Feb; 133(2-3):239-52. PubMed ID: 15740999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CO2 challenge induced HPA axis activation in panic.
    van Duinen MA; Schruers KR; Maes M; Griez EJ
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis function following a 35% CO2 inhalation in healthy volunteers.
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):279-83. PubMed ID: 14751423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual cycle-related sensitivity to 35% CO2 in panic patients.
    Perna G; Brambilla F; Arancio C; Bellodi L
    Biol Psychiatry; 1995 Apr; 37(8):528-32. PubMed ID: 7619975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.